Cancer Statistics, 2017
- PMID: 28055103
- DOI: 10.3322/caac.21387
Cancer Statistics, 2017
Abstract
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data were collected by the National Center for Health Statistics. In 2017, 1,688,780 new cancer cases and 600,920 cancer deaths are projected to occur in the United States. For all sites combined, the cancer incidence rate is 20% higher in men than in women, while the cancer death rate is 40% higher. However, sex disparities vary by cancer type. For example, thyroid cancer incidence rates are 3-fold higher in women than in men (21 vs 7 per 100,000 population), despite equivalent death rates (0.5 per 100,000 population), largely reflecting sex differences in the "epidemic of diagnosis." Over the past decade of available data, the overall cancer incidence rate (2004-2013) was stable in women and declined by approximately 2% annually in men, while the cancer death rate (2005-2014) declined by about 1.5% annually in both men and women. From 1991 to 2014, the overall cancer death rate dropped 25%, translating to approximately 2,143,200 fewer cancer deaths than would have been expected if death rates had remained at their peak. Although the cancer death rate was 15% higher in blacks than in whites in 2014, increasing access to care as a result of the Patient Protection and Affordable Care Act may expedite the narrowing racial gap; from 2010 to 2015, the proportion of blacks who were uninsured halved, from 21% to 11%, as it did for Hispanics (31% to 16%). Gains in coverage for traditionally underserved Americans will facilitate the broader application of existing cancer control knowledge across every segment of the population. CA Cancer J Clin 2017;67:7-30. © 2017 American Cancer Society.
Keywords: cancer cases; cancer statistics; death rates; incidence; mortality.
© 2017 American Cancer Society.
Similar articles
-
Cancer statistics, 2016.CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7. CA Cancer J Clin. 2016. PMID: 26742998
-
Cancer statistics, 2019.CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8. CA Cancer J Clin. 2019. PMID: 30620402
-
Cancer statistics, 2018.CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4. CA Cancer J Clin. 2018. PMID: 29313949
-
Cancer statistics, 2004.CA Cancer J Clin. 2004 Jan-Feb;54(1):8-29. doi: 10.3322/canjclin.54.1.8. CA Cancer J Clin. 2004. PMID: 14974761 Review.
-
Cancers with increasing incidence trends in the United States: 1999 through 2008.CA Cancer J Clin. 2012 Mar-Apr;62(2):118-28. doi: 10.3322/caac.20141. Epub 2012 Jan 4. CA Cancer J Clin. 2012. PMID: 22281605 Review.
Cited by
-
Detection, significance and potential utility of circulating tumor cells in clinical practice in breast cancer (Review).Oncol Lett. 2024 Oct 17;29(1):10. doi: 10.3892/ol.2024.14756. eCollection 2025 Jan. Oncol Lett. 2024. PMID: 39492933 Free PMC article. Review.
-
Survival differences of patients with ureteral versus pelvicalyceal tumours: a systematic review and meta-analysis.Arch Med Sci. 2019 Nov 21;17(3):603-612. doi: 10.5114/aoms.2019.89893. eCollection 2021. Arch Med Sci. 2019. PMID: 34025829 Free PMC article. Review.
-
Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer.Cancer Immunol Immunother. 2021 Oct;70(10):2937-2950. doi: 10.1007/s00262-021-02894-8. Epub 2021 Mar 13. Cancer Immunol Immunother. 2021. PMID: 33713152 Free PMC article.
-
Immune Checkpoint Inhibitors in Lung Cancer: Role of Biomarkers and Combination Therapies.Cureus. 2020 May 13;12(5):e8095. doi: 10.7759/cureus.8095. Cureus. 2020. PMID: 32542150 Free PMC article. Review.
-
Integrated strategy combining endobronchial ultrasound with positron emission tomography to diagnose peripheral pulmonary lesions.Thorac Cancer. 2020 Aug;11(8):2094-2100. doi: 10.1111/1759-7714.13484. Epub 2020 Jun 16. Thorac Cancer. 2020. PMID: 32543098 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous